高级检索

乙型肝炎病毒前S/S区氨基酸与表面抗原清除关联

Association between pre-S/S amino acid variations of hepatitis B virus and hepatitis B surface antigen clearance

  • 摘要:
    目的  分析甘肃省武威市乙型肝炎专病队列表面抗原清除(HBsAg)与乙型肝炎病毒(HBV)前S/S区氨基酸的关联。
    方法  于2018年8月—2022年12月在甘肃省武威市肿瘤医院建立慢性乙型肝炎(CHB)感染者专病队列。随访至2022年12月31日并将HBsAg清除者作为病例组,HBsAg持续阳性为对照组,采集基线调查时的血清样本进行HBV前S/S区二代测序(NGS),计算氨基酸突变率及复杂性。构建稀疏逻辑回归(SLR)模型,分析HBsAg清除与HBV前S/S区氨基酸的关联。
    结果  共纳入171例测序完整的C基因型患者,其中HBsAg清除组23例、持续阳性组148例。HBsAg持续阳性组S区平均突变频率(Z=2.881)及复杂性(Z=3.255)均高于清除组(P<0.05)。共发现121个氨基酸位点的突变率在两组间差异有统计学意义(P<0.05),其中有效突变位点20个,且除H132位点以外均表现为HBsAg持续阳性组高于清除组(P<0.05)。建立SLR模型筛选出HBV DNA、Sn_271、Sn_399、Sn_194、P_121和Sn_397这6个与HBsAg显著相关的特征指标,HBV DNA为最高贡献度指标。
    结论  HBV前S/S区氨基酸位点的改变可能影响HBsAg的清除,SLR模型的应用为CHB精准治疗提供了新的思路。

     

    Abstract:
    Objective Analysis of the association between hepatitis B surface antigen (HBsAg) clearance and amino acid mutations in the pre-S/S region of the hepatitis B virus (HBV) in a cohort from Wuwei city, Gansu province.
    Methods A cohort of chronic hepatitis B (CHB) infected individuals was established at the Wuwei City Tumor Hospital in Gansu province during August 2018 and December 2022. Follow-up continued until December 31, 2022, with individuals who cleared HBsAg designated as the case group and those with persistent HBsAg positivity as the control group. Serum samples collected at baseline were subjected to next-generation sequencing (NGS) of the HBV pre-S/S region. Amino acid mutation rates and complexity were calculated. A sparse logistic regression (SLR) model was constructed to analyze the association between HBsAg clearance and amino acid mutations in the HBV pre-S/S region.
    Results A total of 171 patients with complete genotype C sequences were included, with 23 in the HBsAg clearance group and 148 in the persistent positive group. The average mutation frequency (Z = 2.881) and complexity (Z = 3.255) in the S region were significantly higher in the HBsAg persistent positive group than in the clearance group (P < 0.05). Mutations at 121 amino acid sites showed statistically significant differences between the two groups (P < 0.05), with 20 sites identified as effective mutation sites. Except for site H132, all other sites showed higher mutation rates in the HBsAg persistent positive group than in the clearance group (P < 0.05). An SLR model identified six characteristic indicators significantly associated with HBsAg clearance: HBV DNA, Sn_271, Sn_399, Sn_194, P_121, and Sn_397, with HBV DNA having the highest contribution.
    Conclusions Changes in amino acid sites in the HBV pre-S/S region may influence HBsAg clearance. The application of the SLR model provides new insights for precision treatment of CHB.

     

/

返回文章
返回